Alzheimer Disease Clinical Trials in Beijing, Beijing Municipality
8 recruitingBeijing, Beijing Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled157 locationsNCT07011732
Recruiting
Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Alzheimer Disease
Karuna Therapeutics406 enrolled278 locationsNCT06585787
Recruiting
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital750 enrolled1 locationNCT07089303
Recruiting
Phase 3
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
Alzheimer DiseaseNeurofibrillary Tangle
Sinotau Pharmaceutical Group354 enrolled1 locationNCT07115238
Recruiting
Biomarker-based Alzheimer's Disease Cohort Study (BASIC)
Alzheimer Disease
Xuanwu Hospital, Beijing2,835 enrolled1 locationNCT07109999
Recruiting
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
EpilepsyAlzheimer DiseaseParkinson Disease+1 more
Xuanwu Hospital, Beijing2,300 enrolled1 locationNCT06092125
Recruiting
Not Applicable
The Ketogenic Diet in the Treatment of Alzheimer's Disease
Alzheimer Disease
Capital Medical University300 enrolled1 locationNCT06681948
Recruiting
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
ImageAlzheimer Disease
Ruijin Hospital1,000 enrolled8 locationsNCT06534658